Tolcher, A. W., Spira, A. I., Meric-Bernstam, F., Gordon, M. S., Olszanski, A. J., Klempner, S. J., Robillard, M., Orford, K. W., Sen, S. (2026). Phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of TGW101 in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3163